Industries > Pharma > Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018

Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018

Financial Performances, Services, Capacities, Mergers & Acquisitions, SWOT Analysis

PUBLISHED: 28 September 2018
PAGES: 257
PRODUCT CODE: PHA0334
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

Contract manufacturing represents the largest sector of the pharma outsourcing industry. Pharmaceutical companies have sought to take advantage of the benefits of contract manufacturing – lower costs, increased flexibility and external expertise – to focus resources on core competencies in drug development and marketing.

CMOs are increasingly seen as a strategic partner for pharmaceutical companies, providing a one-stop-shop of services for formulation development and manufacturing throughout the lifecycle of a drug.

The market-leading CMOs have grown through acquisitions and site expansions to offer almost all required services on a global scale. However, there is still a role to be played by specialist CMOs, particularly those that offer biological drug manufacturing services.

This updated study discusses market-leading companies worldwide, as well as the strategies they have employed to develop in recent years. Visiongain’s research and analysis explore opportunities and challenges for the top 50 pharma contract manufacturing organisations.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 257-page report you will receive 189 charts– all unavailable elsewhere.

The 257-page report provides clear detailed insight into the leading pharmaceutical contract manufacturing organizations. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
• Global Pharmaceutical Contract Manufacturing Market Size in 2017

• Pharmaceutical Contract Manufacturing Market Size in 2017 segmented by national market:
• US
• EU
• China
• Japan
• India
• Brazil
• Russia
• South Korea
• Others

• Discussion and analysis of factors that drive and restrain the pharmaceutical contract manufacturing market

• Profiles of the 50 leading pharmaceutical contract manufacturing organizations:
• AbbVie Contract Manufacturing
• Aenova Group
• Aesica Pharmaceuticals
• Ajinomoto Althea, Inc.
• Albany Molecular Research, Inc.
• Alcami Corporation
• Alkermes plc
• Almac Group
• Amatsigroup
• Aurobindo Pharma Ltd.
• Avid Bioservices Inc.
• Bayer AG
• Baxter Biopharma Solutions
• Biomay AG
• Boehringer Ingelheim GmbH
• Catalent Pharma Solutions Inc.
• Charles River Laboratories International Inc.
• Cardinal Health
• Corden Pharmaceutical
• Daito Pharmaceutical
• Delpharm
• Divis Laboratories Ltd.
• Dr. Reddy’s Laboratories Ltd.
• DPT Laboratories
• Esteve Química
• Evonik Degussa
• Famar Health Care Services
• Fareva
• Fujifilm Diosynth Biotechnologies UK Ltd.
• GlaxoSmithKline plc
• Huapont Medical
• Lonza Group Ltd.
• Nipro Corporation
• Paragon Bioservices Inc
• Patheon Inc
• Pfizer Inc./Pfizer CentreSource (PCS)
• Piramal Healthcare L
• Recipharm A
• Roche
• Royal DSM NV
• Shandong Xinhua Pharmaceutical
• Siegfried
• Teva API
• Therapure Biopharma Inc.
• UPM Pharmaceuticals Inc.
• Vetter Pharmacuticals
• Xcelience LLC
• Xcellerex LLC
• Zhejiang Hisun Pharmaceutical
• Zhejiang Huahai Pharmaceuticals

Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018

• The content of each profile differs, depending on the organization. In general, a profile gives the following information:
• Overview of the company’s contract manufacturing services and operations
• Analysis of recent financial performance – annual revenue for CMO services, including some data on operating profit and margins
• Assessment of developments – activities, acquisitions, production capacity, deals, new service offerings and collaborations
SWOT analysis – a firm’s strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth

Visiongain’s study is intended for anyone requiring commercial analyses for pharmaceutical contract manufacturing market. You find data, trends and predictions.

Buy our report today Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018: Financial Performances, Services, Capacities, Mergers & Acquisitions, SWOT Analysis.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2018


Latest Pharma news

“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain

It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.

16 October 2019

READ

“Global nephrology and urology devices market is anticipated to surpass USD 39 Bn by 2030”, says Visiongain

Nephrology is a field of medicine that is concerned with studying kidney function, treating kidney issues, and therapy for renal substitute.

16 October 2019

READ

“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain

Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

16 October 2019

READ

“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain

The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.

16 October 2019

READ

Categories

Category